The decision to open-source the code, supported by Microsoft, aims to democratize AI tools in biomedicine. Researchers worldwide can now use and modify architecture that was previously available only to major pharma companies. This is a significant step toward reproducible and open science, where routine intellectual tasks are delegated to digital assistants.
Source: Insilico Medicine
Insilico MedicineOpen SourceMulti-AgentBioTechScience